Literature DB >> 17123285

Model for end-stage liver disease (MELD) exception guidelines.

Russell Wiesner1, John R Lake, Richard B Freeman, Robert G Gish.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17123285     DOI： 10.1002/lt.20961

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  13 in total

1.  The impact of MELD allocation on simultaneous liver-kidney transplantation.

Authors:  Julie A Thompson; John R Lake
Journal:  Curr Gastroenterol Rep       Date:  2009-02

2.  Validation of the Brazilian version of Chronic Liver Disease Questionnaire.

Authors:  Samantha Mucci; Vanessa de Albuquerque Citero; Adriano Miziara Gonzalez; Luciana Geocze; Stephan Geocze; Gaspar de Jesus Lopes Filho; Mario Alfredo De Marco; Edison Roberto Parise; Luiz Antonio Nogueira Martins
Journal:  Qual Life Res       Date:  2012-03-03       Impact factor: 4.147

Review 3.  Model for End-stage Liver Disease.

Authors:  Ashwani K Singal; Patrick S Kamath
Journal:  J Clin Exp Hepatol       Date:  2012-12-01

Review 4.  Model for end-stage liver disease: end of the first decade.

Authors:  Sumeet K Asrani; W Ray Kim
Journal:  Clin Liver Dis       Date:  2011-10-01       Impact factor: 6.126

5.  MELD Exceptions and Rates of Waiting List Outcomes.

Authors:  A B Massie; B Caffo; S E Gentry; E C Hall; D A Axelrod; K L Lentine; M A Schnitzler; A Gheorghian; P R Salvalaggio; D L Segev
Journal:  Am J Transplant       Date:  2011-09-15       Impact factor: 8.086

Review 6.  Model for end-stage liver disease score and MELD exceptions: 15 years later.

Authors:  Sumeet K Asrani; Patrick S Kamath
Journal:  Hepatol Int       Date:  2015-05-28       Impact factor: 6.047

Review 7.  Kidney, pancreas and liver allocation and distribution in the United States.

Authors:  J M Smith; S W Biggins; D G Haselby; W R Kim; J Wedd; K Lamb; B Thompson; D L Segev; S Gustafson; R Kandaswamy; P G Stock; A J Matas; C J Samana; E F Sleeman; D Stewart; A Harper; E Edwards; J J Snyder; B L Kasiske; A K Israni
Journal:  Am J Transplant       Date:  2012-11-16       Impact factor: 8.086

8.  Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation.

Authors:  Joel Wedd; Kiran M Bambha; Matt Stotts; Heather Laskey; Jordi Colmenero; Jane Gralla; Scott W Biggins
Journal:  Liver Transpl       Date:  2014-08-26       Impact factor: 5.799

Review 9.  Hepatocellular carcinoma: A comprehensive review.

Authors:  Lisa P Waller; Vrushak Deshpande; Nikolaos Pyrsopoulos
Journal:  World J Hepatol       Date:  2015-11-18

Review 10.  Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine.

Authors:  Tsang Lau; Jawad Ahmad
Journal:  Hepat Med       Date:  2013-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.